Genes: DNA, inheritance and DNA technology: Changing organisms: breeding, GM crops and gene editing
All courses / Understanding Science / Module 14: Genes: DNA, inheritance and DNA technology Part 6 of 6Changing organisms: breeding, GM crops and gene editing
People have changed heredity for ten thousand years by choosing parents. DNA technology lets them add or edit a single gene. The account keeps to principles, history and policy, not protocols.
6.1 Selective breeding and hybrid vigour changed crops long before DNA was known, and Mendel's ratios explain why hybrid seed is bought afresh
Every crop in a field has been changed by choosing seed from the best plants for many generations. Maize came from a wild grass, teosinte. In the 1960s semi-dwarf wheats, which carry heavy grain without falling over, lifted India's yields. All of this is selection among existing variants, with mutation as the source of new ones.
Hybrid vigour is more specific. George Shull found in 1908 that inbred maize lines, made by repeated self-pollination, become weak and small, while a cross between two unrelated inbred lines gives plants taller and higher-yielding than either parent. Many plants carry a few faulty alleles that do little harm next to a working copy. Inbreeding pairs them up. A cross of two inbred lines covers each line's faults with the other's good copies. The node 'Hybrid vigour (heterosis)' gives the evidence, including the rise of hybrid maize in Iowa from under 10 per cent of acreage to over 90 per cent in the late 1930s. Whether hidden faults or heterozygote advantage matters more is still debated.
India has a notable first. The cotton hybrid H-4, developed by C. T. Patel at Surat in Gujarat in 1970 (one account gives its release as 1971), is described as the world's first commercial cotton hybrid.
The farmer's problem comes from Mendel. The seed from a hybrid crop is the second generation, in which alleles are sorted again. Suppose vigour needs the heterozygote at n independent genes. In the first generation every plant is a heterozygote at all of them. In the second, each gene is a heterozygote with chance half, so only (1/2)^n of plants are at all n. That is why hybrid seed is bought again each season.
| Genes n where the heterozygote is needed | Fraction of first-generation (F1) plants at all n | Fraction of second-generation (F2) plants at all n |
|---|---|---|
| 1 | 100% | 1/2 = 50% (calculated) |
| 3 | 100% | 1/8 = 12.5% (calculated) |
| 5 | 100% | 1/32 = 3.1% (calculated) |
| 10 | 100% | 1/1,024 = 0.1% (calculated) |
A simplified model in which vigour needs every gene heterozygous. Real vigour is a graded sum, so the loss is less steep, but it is real and measured in many crops.
Source: Hewitt, Lyons, Suchocki and Yeh, Conceptual Integrated Science, 2nd edition (Pearson, 2013), ch. 16, 'Genetics'- Hewitt, Lyons, Suchocki and Yeh, Conceptual Integrated Science, 2nd edition (Pearson, 2013) · ch. 16, 'Genetics'
- Standard histories of genetics, as summarised in Encyclopaedia Britannica (Gregor Mendel; Rosalind Franklin; Francis Crick; James Watson; DNA; Meselson-Stahl) and the Nobel Prize site (Physiology or Medicine 1962, 1968, 1978 and 1980; Chemistry 1993) · dates and findings for Mendel (read 1865, published 1866, rediscovered 1900), Sutton and Boveri (1902 to 1903), Morgan (1910), Griffith (1928), Avery, MacLeod and McCarty (1944), Hershey and Chase (1952), Chargaff, Franklin and Gosling (Photo 51, 1952), Watson and Crick (Nature, 25 April 1953), Meselson and Stahl (1958), Crick and others (1961), Nirenberg and Matthaei (1961), Jacob and Monod (1961), Luria and Delbruck (1943), Cohen and Boyer (1973), Sanger (1977), Mullis (1983). Checked in November 2026: Mendel read 8 February and 8 March 1865, printed 1866 (Villanova Mendel text); Photo 51 taken May 1952 and published in Nature on 25 April 1953 beside Watson and Crick (King's College London); Meselson and Stahl at Caltech, PNAS 44 (1958) (Arizona State University Embryo Project); Mullis developed PCR in 1983 at Cetus, Nobel 1993 (Britannica)
- Textile Excellence, Researchers say it is time India moves on from hybrids; and B. G. Solanki, presentation to ICAC (2017) · web
6.2 Bt cotton puts a bacterial insecticide gene into the plant, and India's experience since 2002 shows both the gains and the limits
A transgenic organism carries a gene moved from another species. The soil bacterium Bacillus thuringiensis makes crystal proteins (Cry proteins) that kill certain insects. When a moth caterpillar eats them, the alkaline gut dissolves the crystal and the toxin binds to receptors on gut cells and punches pores, so the larva stops feeding and dies. Humans, with a very acid stomach and no such receptors, are not affected. Sprays of the bacterium have been used in organic farming for decades. Plant scientists inserted the gene for one Cry protein into cotton, usually with Agrobacterium, a soil bacterium that naturally moves DNA into plants.
India's regulator, the Genetic Engineering Appraisal Committee (GEAC) of the environment ministry, approved three of Mahyco's Bt cotton hybrids, carrying the Cry1Ac gene, in March 2002. A two-gene version (Cry1Ac and Cry2Ab) followed in 2006. By about 2012, according to one trade review, around 90 per cent of cotton area was Bt.
The national figures below show what happened. Yield rose, production rose faster still, and the share of India's insecticide used on cotton is reported to have fallen from 46 per cent in 2001 to under 26 per cent after 2006. But yield also depended on better seed, rainfall, irrigation and area, so how much was due to Bt is argued, and studies disagree on size. What is clear is that Bt cotton replaced a number of sprays against the American bollworm.
The limits are biological. Insects evolve. Pink bollworm larvae were found surviving on Bt cotton in Gujarat from 2010, and ICAR-CICR confirmed resistance to Cry1Ac, Cry2Ab and the pair in 2014 studies. The advice is a refuge of non-Bt plants (a 95: 5 mix), early-maturing varieties and destruction of crop residue, so that susceptible insects keep mixing with resistant ones.
| Quantity | 2002-03 | 2011-12 | Ratio |
|---|---|---|---|
| Area, lakh hectares | 76.67 | 121.91 | 1.59 (calculated) |
| Yield, kg of lint per hectare | 302 | 481 | 1.59 (calculated) |
| Production, lakh bales of 170 kg | 136 | 345 | 2.54 (calculated) |
| Check: area x yield | 76.67 x 302 = 23,154 lakh kg (calculated) | 121.91 x 481 = 58,639 lakh kg (calculated) | 58,639 / 23,154 = 2.53 (calculated), the same as production |
Units: lakh hectares x kg per hectare = lakh kg. 1.59 x 1.59 = 2.53 (calculated). The bales check: 345 lakh bales x 170 kg = 5.9 million tonnes of lint, and 58,639 lakh kg is the same 5.9 million tonnes (calculated). Changes in area, seed, water and weather are all mixed into these ratios.
Source: BioSpectrum India, Beyond the boom: 10 years of Bt cotton, https://www.biospectrumindia.com/news/95/1121/beyond-the-boom-10-years-of-bt-cotton.html (Mahyco Bollgard event approved 2002; Bollgard II 2006; about 90 per cent of cotton area under Bt; Cotton Advisory Board table: yield 302 kg/ha in 2002-03 to 481 kg/ha in 2011-12, production 136 to 345 lakh bales, area 76.67 to 121.91 lakh hectares; insecticide share falling from 46 per cent in 2001 to under 26 per cent after 2006)- Hewitt, Lyons, Suchocki and Yeh, Conceptual Integrated Science, 2nd edition (Pearson, 2013) · ch. 16, 'Genetics'
- BioSpectrum India, Beyond the boom: 10 years of Bt cotton · web
- ICAR-Central Institute for Cotton Research, Pink bollworm advisory (PA 27) · web
- CorpWatch, India: Government approves use of Bt cotton (27 March 2002) · web
6.3 CRISPR turned a bacterial immune system into a programmable editor, and the first approved therapy arrived in 2023
The node 'CRISPR-Cas immunity in bacteria' tells how bacteria record the DNA of viruses that attacked them and use RNA copies of those records to guide an enzyme, Cas, to cut matching viral DNA. In 2007 workers at a dairy-culture company showed by experiment that adding a virus's piece to a bacterium's array made it resistant to that virus.
In 2012 Emmanuelle Charpentier and Jennifer Doudna, with colleagues, showed in Science that the Cas9 enzyme and a single, designed guide RNA would cut a chosen DNA sequence in a test tube. The principle is simple. The guide RNA holds about 20 letters that pair with a matching stretch of DNA beside a short marker sequence. Where the match is found, Cas9 cuts both strands. The cell then repairs the break. Repair by simple joining often leaves small errors that disable the gene. If a template is supplied, the cell may copy it and a precise change is made. In 2013 groups, among them Feng Zhang's and George Church's, showed it working in human cells. Charpentier and Doudna received the 2020 Nobel Prize in Chemistry 'for the development of a method for genome editing'.
The tool is not perfect. Cuts can occur at near-matches elsewhere, the editor has to be delivered into the right cells, and a cell's repair is not always the intended one.
The first approved medicine is Casgevy. On 16 November 2023 the UK regulator authorised it for sickle cell disease and a related blood disorder in people aged 12 or older. Blood stem cells are removed, edited in the laboratory so that they make more foetal haemoglobin, and returned. This is edited cells in one person (somatic), not changes that pass to children. Earlier gene therapy has used harmless viruses to deliver a working copy of a gene.
the guide pairs with matching DNA next to a short marker
2 CutCas9 cuts both strands at that place
3 Repair by the cellerrors in joining disable the gene, or a supplied template gives a precise edit
Outputs An edited genechecked by sequencing, since off-target edits can occurOnly the logic is shown here.
Source: Pharmaceutical Technology, World's first CRISPR-based gene therapy approved for sickle cell anaemia (16 November 2023), https://www.pharmaceutical-technology.com/newsletters/worlds-first-crispr-based-gene-therapy-approved-for-sickle-cell-anaemia (UK MHRA conditional authorisation of Casgevy, for sickle cell disease and transfusion-dependent beta-thalassaemia in people aged 12 and over; the patient's own blood stem cells are edited to make more foetal haemoglobin)- Hewitt, Lyons, Suchocki and Yeh, Conceptual Integrated Science, 2nd edition (Pearson, 2013) · ch. 16, 'Genetics'
- The Nobel Prize in Chemistry 2020 (Charpentier and Doudna, for the development of a method for genome editing) and 1993 (Mullis, for the invention of the polymerase chain reaction method) · Motivation 'for the development of a method for genome editing', as quoted by the Royal Swedish Academy of Sciences, https://www.kva.se/en/news/nobelpriset-i-kemi-2020-2/; 1993 prize to Mullis for the invention of the polymerase chain reaction method
- Pharmaceutical Technology, World's first CRISPR-based gene therapy approved for sickle cell anaemia (16 November 2023) · web
- Standard histories of genetics, as summarised in Encyclopaedia Britannica (Gregor Mendel; Rosalind Franklin; Francis Crick; James Watson; DNA; Meselson-Stahl) and the Nobel Prize site (Physiology or Medicine 1962, 1968, 1978 and 1980; Chemistry 1993) · dates and findings for Mendel (read 1865, published 1866, rediscovered 1900), Sutton and Boveri (1902 to 1903), Morgan (1910), Griffith (1928), Avery, MacLeod and McCarty (1944), Hershey and Chase (1952), Chargaff, Franklin and Gosling (Photo 51, 1952), Watson and Crick (Nature, 25 April 1953), Meselson and Stahl (1958), Crick and others (1961), Nirenberg and Matthaei (1961), Jacob and Monod (1961), Luria and Delbruck (1943), Cohen and Boyer (1973), Sanger (1977), Mullis (1983). Checked in November 2026: Mendel read 8 February and 8 March 1865, printed 1866 (Villanova Mendel text); Photo 51 taken May 1952 and published in Nature on 25 April 1953 beside Watson and Crick (King's College London); Meselson and Stahl at Caltech, PNAS 44 (1958) (Arizona State University Embryo Project); Mullis developed PCR in 1983 at Cetus, Nobel 1993 (Britannica)
- LiveLaw, Body before birth: can Article 21 shield the genome from non-consensual CRISPR editing? · web
6.4 Governments decide how these technologies are used, and India's rules on GM crops, edited crops and research show the trade-offs
At the international level the Cartagena Protocol of 2000 sets rules for moving living modified organisms between countries. In India, GM crops come under rules made in 1989 under the Environment (Protection) Act, and the GEAC appraises each application.
Bt cotton, cleared in 2002, is now nearly universal. Bt brinjal was approved by the GEAC in October 2009, but on 9 February 2010 the environment minister, Jairam Ramesh, imposed a moratorium after public consultations, and it has not been grown commercially. In 2022 the GEAC conditionally cleared a GM mustard hybrid, DMH-11, for environmental release. On 23 July 2024 two Supreme Court judges split on it, sending it to a larger bench, and the Court told the Union government to frame a national GM crop policy with states and farmers.
Genome editing raised a new question. If an edit only deletes or changes letters and leaves no foreign DNA, is the plant a GM crop? India's environment ministry answered on 30 March 2022: SDN-1 and SDN-2 edits that leave no foreign DNA in the final plant are exempt from the main 1989 biosafety rules. In May 2025 ICAR released two rice varieties made with SDN-1 edits: DRR Dhan 100 Kamala, from Samba Mahsuri, reported to yield more and mature earlier, and Pusa DST Rice 1, from MTU 1010, bred for salty and alkaline soils. The release drew praise for speed and concern about transparency and seed control.
What can go wrong? Resistance in pests, as with pink bollworm. Spread of genes to wild relatives. Doubts about food safety and labelling, though large reviews have found GM foods no riskier than conventionally bred ones. Costs and licence terms that shift power to seed companies. And misuse, met in principle by screening orders for made-to-order DNA and by controlling access to dangerous organisms. A fair assessment weighs benefit, risk and who decides.
| Year | Event |
|---|---|
| 1973 | Cohen and Boyer make recombinant DNA in bacteria |
| 1975 | Asilomar meeting agrees safety guidelines |
| 1983 | Mullis conceives PCR |
| 1996 | Dolly the sheep is born |
| 2002 | India's GEAC approves Bt cotton |
| 2003 | Human Genome Project completed (NHGRI) |
| 2012 | Charpentier, Doudna and colleagues show programmable Cas9 cutting |
| 2020 | Nobel Prize in Chemistry for genome editing |
| 2022 | Complete human genome sequence (T2T-CHM13) |
| 2022 | India exempts SDN-1 and SDN-2 genome-edited plants from the main GM rules |
| 2023 | First CRISPR-based therapy authorised in the UK |
| 2024 | Indian Supreme Court asks for a national GM crop policy |
| 2025 | ICAR releases two genome-edited rice varieties |
The years come from the sources listed for this module.
Source: Hewitt, Lyons, Suchocki and Yeh, Conceptual Integrated Science, 2nd edition (Pearson, 2013), ch. 16, 'Genetics'- Hewitt, Lyons, Suchocki and Yeh, Conceptual Integrated Science, 2nd edition (Pearson, 2013) · ch. 16, 'Genetics'
- LiveLaw, Supreme Court on GM mustard: evolve a national policy on GM crops (24 July 2024) · web
- Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994; Environment (Protection) Act rules of 1989 under which GEAC works · statutory background: the 1994 Act bans prenatal sex determination; the 1989 Rules govern genetically engineered organisms
- Rural Voice, Genome-edited plants exempted from biosafety regulations (30 March 2022) · web
- Centre for Science and Environment, Moratorium on Bt brinjal: Jairam Ramesh (9 February 2010) · web
- All India Radio News, India's first genome-edited rice varieties launched (4 May 2025), and Drishti IAS, Genome-edited rice varieties (6 May 2025) · web
See it in the table
Mz MaizeRi RiceCt CottonCheck your understanding
Why can a farmer not save seed from a hybrid crop and expect the same vigour?
In the second generation each gene is a heterozygote only half the time, so full vigour is rare, as Mendel's ratios predict.Which is a limit of Bt cotton, as shown by the pink bollworm experience?
Larvae surviving on Bt cotton were reported from 2010, and resistance was confirmed in 2014 studies. Refuges keep susceptible insects around.What is the main difference between editing a patient's blood stem cells and editing an embryo?
Somatic edits stop with the patient and are regulated like medicines. Heritable edits would pass on, which is why they are widely not permitted.